This could materially accelerate: Prescription growth Physician adoption Long-term obesity treatment uptake 2 Oral GLP-1 vs injectable GLP-1 = market expansion, not cannibalization The strategy here is smart: Foundayo = first once-daily oral GLP-1 for obesity with no food or water restrictions Zepbound = most-prescribed injectable obesity therapy in the U.S
Dysregulated adipokines highlight opportunities for intervention: agents that increase adiponectin signaling may restore insulin sensitivity and reduce steatosis
If you are administering B12 injections, choosing the appropriate needle is essential for a seamless, pain-free experience
In our model, depletion of Hypoxia-Inducible Factor 1 alpha (HIF-1) impaired the effects of Exendin-4 on glucose metabolism, while pharmacological inhibition of Phosphoinositide 3-kinase (PI3K) or mTOR completely abolished such effects
Every patient who rebalances their microbiome notices a transformation not just in digestion but in energy, skin, mood, and clarity